Iboga is a plant. Ibogaine is one of its compounds. Understanding that difference—and the limits of what we know—is a better starting point than a treatment promise.
“Iboga” and “ibogaine” are sometimes used as if they mean the same thing. The material, composition, and context can be very different.
Tabernanthe iboga
A shrub native to Central Africa. Its root bark contains a mixture of naturally occurring alkaloids, including ibogaine.
A psychoactive alkaloid
One of the compounds found in iboga. It has been investigated for substance-use disorders and is used in some treatment settings.
And “total alkaloid” extracts? These contain a mixture of alkaloids rather than ibogaine alone. Names such as “TA”, “extract”, or “purified” do not, by themselves, verify identity, potency, purity, or safety.
Iboga has deep cultural significance in Central Africa, particularly in Gabon, where it is used within diverse Bwiti spiritual traditions. These traditions encompass community, initiation, healing, and relationships with ancestors—not simply the effects of a substance.
Practices differ between communities. Describing iboga only as a modern treatment tool leaves out the people, knowledge, and living traditions connected to it.
Traditional use is not proof of safety in a clinical setting. Equally, medical research does not replace cultural knowledge. Respectful discussion keeps those contexts distinct and takes questions of consent, sourcing, and ecological sustainability seriously.
Some studies report reductions in opioid withdrawal symptoms and craving after ibogaine. Much of the published human evidence comes from small, observational studies rather than large, well-controlled trials.
Without robust comparison groups, it is difficult to separate a drug’s effects from other care, participant selection, expectations, or changes over time.
Withdrawal relief does not establish long-term benefit. Substance-use disorders often require continuing medical, psychological, and social support.
Ibogaine can prolong the heart’s QT interval and trigger dangerous arrhythmias. Fatalities have been reported. Health conditions, medication interactions, and other substances can increase risk.
Read beyond individual testimonials: find systematic reviews on PubMed. Review study design, follow-up, adverse events, and conflicts of interest—not just the headline.
Continue exploring at ibogaine.nzA few distinctions to keep in mind when reading research, hearing personal stories, or speaking with a provider.
No. Plant origin does not make a substance safe. Iboga contains ibogaine and other active compounds, and its composition can vary. Serious risks apply to plant preparations as well as isolated ibogaine. See the safety guide for the clinical questions that matter.
People report vivid dream-like imagery, changes in perception, and emotionally intense experiences. Nausea, vomiting, impaired coordination, and exhaustion may also occur. Effects can be prolonged and unpredictable. A meaningful subjective experience is not evidence of medical benefit, and serious complications may not be obvious to the person experiencing them.
No reliable evidence supports calling ibogaine a cure. Reports of reduced withdrawal or craving should not be confused with established long-term recovery. Discuss evidence-based treatment options with a qualified clinician, including ongoing support and overdose prevention. Reduced opioid tolerance after a period of abstinence can make a return to use especially dangerous.
No. Legal status, medicine approval, provider qualifications, and clinical safety are separate questions. Rules vary by country and can change. In New Zealand, check current requirements with Medsafe and a qualified health professional rather than relying on a seller’s or provider’s claims.
Ask what material is being proposed, what evidence supports its use, and how identity and composition are verified. Ask about medical screening, medication interactions, cardiac monitoring, emergency transfer, and follow-up care. Do not stop prescribed medicines on your own. Use the preparation guide to organise your questions.
Keep preparation, support, and life after treatment in view. Explore the Treatment Companion App at ibogaine.org.nz alongside—not instead of—conversations with your care team.
Considering your next step? Start with your questions, not a commitment to treatment.
Explore the companion app A supporting resource—not a substitute for clinical care.Understand screening, heart health, and why professional monitoring matters.